Viridian Therapeutics Inc (VRDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Sales | 8,386 | 4,003 | 3,477 | 2,538 | 4,320 |
| Cost of Goods | N/A | N/A | N/A | 2,472 | 3,366 |
| Gross Profit | 8,386 | 4,003 | 3,477 | 66 | 954 |
| Operating Expenses | 41,470 | 30,535 | 20,464 | 11,725 | 8,187 |
| Operating Income | -33,084 | -26,532 | -16,987 | -11,187 | -6,867 |
| Interest Expense | 873 | 383 | 326 | 141 | 1,023 |
| Other Income | 1,254 | 403 | 39 | 0 | 0 |
| Pre-tax Income | -32,703 | -26,512 | -17,274 | -11,328 | -7,890 |
| Net Income Continuous | -32,703 | -26,512 | -17,274 | -11,328 | -7,890 |
| Net Income | $-32,703 | $-26,512 | $-17,274 | $-11,328 | $-7,890 |
| EPS Basic Total Ops | -16.49 | -20.69 | -422.94 | -315.14 | -786.71 |
| EPS Basic Continuous Ops | -16.56 | -20.65 | -421.79 | -315.09 | -786.12 |
| EPS Diluted Total Ops | -16.49 | -20.69 | -422.94 | -315.14 | -786.71 |
| EPS Diluted Continuous Ops | -16.56 | -20.65 | -421.79 | -315.09 | -786.12 |
| EPS Diluted Before Non-Recurring Items | -16.49 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-33,219 | $-26,224 | $-16,646 | $-11,003 | $-6,723 |